A U.S. congressional subcommittee looking into the alleged use of fraudulent clinical data to support approval of the antibiotic drug Ketek (telithromycin) voted on January 29, 2008, to subpoena four ... Read More

On January 31, 2008, at 4:00 p.m. CST, doctors at Saint Joseph's Hospital in Marshfield, Wisconsin, will present a webcast, "Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease ... Read More

You’ve heard terms like genes, DNA, the Human Genome Project, and chromosomes. But what do these words mean exactly? Increase your genetic vocabulary so you’ll understand more about genetic disorders. Photo ... Read More

I'd heard that extracting DNA (the genetic material in cells) was actually easy, and that schoolchildren could do it. I admit I was skeptical until I found a school science ... Read More

The First International Symposium on Human Embryonic Stem Cell Research (FISH-ESC) will be held January 31-February 2, 2008, in Evry, France. According to the symposium Web site, scientists from around ... Read More

Leigh's disease is an inherited metabolic disorder that damages the central nervous system (brain, spinal cord, and optic nerves). Leigh's disease is caused by problems in the mitochondria, the energy ... Read More

A research team has identified a gene associated with X-linked spinal muscular atrophy (XL-SMA), a motor neuron disease. The researchers screened 6 XL-SMA families and found mutations in the ubiquitin-activating ... Read More

On January 4, 1983, the U.S. Orphan Drug Act was passed by Congress and signed into law by then-President Ronald Reagan. Prior to the passage of the Act, only 10 ... Read More

On January 6, 2008, the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) opened its application period for fiscal year 2009 grant awards to support clinical ... Read More

This is a list of the orphan drugs (specialty drugs to treat rare disorders or conditions) approved by the U.S. Food and Drug Administration (FDA) for marketing in the United ... Read More

A study designed to examine the effect of long-term treatment with Soliris (eculizumab) in individuals with paroxysmal nocturnal hemoglobinuria (PNH), a disorder in which abnormal breakdown of red blood cells ... Read More